SCHEMBL25159581

SCHEMBL25159581

CCOC(=O)[C@H](O)/C=C/c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
CTDSP1 Q9GZU7 1/20 0.50
RAB9A P51151 4/20 0.48
NPC1 O15118 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
LMNA P02545 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
MMP8 P22894 2/20 0.48
ALDH1A1 P00352 5/20 0.47
KDM4E B2RXH2 3/20 0.47
HPGD P15428 2/20 0.47
GLA P06280 1/20 0.47
MAPT P10636 2/20 0.47
ADORA3 P0DMS8 1/20 0.47
XBP1 P17861 1/20 0.47
PIN1 Q13526 1/20 0.46
CYP1A2 P05177 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28319517 1.00 MEN1 (0.51) MEN1KMT2ACTDSP1RAB9ANPC1
SCHEMBL6067669 0.85 MEN1 (0.53) MEN1KMT2ACTDSP1RAB9ANPC1
SCHEMBL31376543 0.84 MEN1 (0.49) MEN1KMT2ACTDSP1RAB9ANPC1
SCHEMBL9657897 0.83 CASP1 (0.53) MEN1KMT2ACTDSP1RAB9ANPC1
SCHEMBL3070374 0.83 CYP1A2 (0.47) KMT2ALMNASMN1; SMN2ALDH1A1GLA
SCHEMBL11988772 0.83 CYP1A2 (0.47) KMT2ALMNASMN1; SMN2ALDH1A1GLA
SCHEMBL3070378 0.83 CYP1A2 (0.47) KMT2ALMNASMN1; SMN2ALDH1A1GLA
SCHEMBL13250875 0.83 MEN1 (0.47) MEN1KMT2ACTDSP1RAB9ANPC1
SCHEMBL13272157 0.83 MEN1 (0.47) MEN1KMT2ACTDSP1RAB9ANPC1
SCHEMBL27978308 0.82 MEN1 (0.50) MEN1KMT2ACTDSP1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4257593-A1 CHIRAL MULTIDENTATE LIGAND AND USE THEREOF IN ASYMMETRIC HYDROGENATION SHENZHEN CATALYS TECHNOLOGY CO., LTD. (CN) 2023-10-11 EP disclosed
WO-2023077643-A1 CHIRAL MULTIDENTATE LIGAND AND USE THEREOF IN ASYMMETRIC HYDROGENATION 凯特立斯(深圳)科技有限公司 2023-05-11 WO disclosed
US-20230124576-A1 CHIRAL MULTIDENTATE LIGAND, AND APPLICATION THEREOF IN ASYMMETRIC HYDROGENATION SHENZHEN CATALYS TECHNOLOGY CO., LTD (CN) 2023-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230124576-A1 CHIRAL MULTIDENTATE LIGAND, AND APPLICATION THEREOF IN ASYMMETRIC HYDROGENATION H1-4, CHRM1, CHRM2 MEN1 39/4885KMT2A 582/4885CTDSP1 904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.